Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 1/2018

Open Access 01-12-2018 | Research

Epidemiology of sepsis in intensive care units in Turkey: a multicenter, point-prevalence study

Authors: Nur Baykara, Halis Akalın, Mustafa Kemal Arslantaş, Volkan Hancı, Çiğdem Çağlayan, Ferda Kahveci, Kubilay Demirağ, Canan Baydemir, Necmettin Ünal, Sepsis Study Group

Published in: Critical Care | Issue 1/2018

Login to get access

Abstract

Background

The prevalence and mortality of sepsis are largely unknown in Turkey, a country with high antibiotic resistance. A national, multicenter, point-prevalence study was conducted to determine the prevalence, causative microorganisms, and outcome of sepsis in intensive care units (ICUs) in Turkey.

Methods

A total of 132 ICUs from 94 hospitals participated. All patients (aged > 18 years) present at the participating ICUs or admitted for any duration within a 24-h period (08:00 on January 27, 2016 to 08:00 on January 28, 2016) were included. The presence of systemic inflammatory response syndrome (SIRS), severe sepsis, and septic shock were assessed and documented based on the consensus criteria of the American College of Chest Physicians and Society of Critical Care Medicine (SEPSIS-I) in infected patients. Patients with septic shock were also assessed using the SEPSIS-III definitions. Data regarding demographics, illness severity, comorbidities, microbiology, therapies, length of stay, and outcomes (dead/alive during 30 days) were recorded.

Results

Of the 1499 patients included in the analysis, 237 (15.8%) had infection without SIRS, 163 (10.8%) had infection with SIRS, 260 (17.3%) had severe sepsis without shock, and 203 (13.5%) had septic shock. The mortality rates were higher in patients with severe sepsis (55.7%) and septic shock (70.4%) than those with infection alone (24.8%) and infection + SIRS (31.2%) (p < 0.001). According to SEPSIS-III, 104 (6.9%) patients had septic shock (mortality rate, 75.9%). The respiratory system (71.6%) was the most common site of infection, and Acinetobacter spp. (33.7%) were the most common isolated pathogen. Approximately, 74.9%, 39.1%, and 26.5% of Acinetobacter, Klebsiella, and Pseudomonas spp. isolates, respectively, were carbapenem-resistant, which was not associated with a higher mortality risk. Age, acute physiology and chronic health evaluation II score at ICU admission, sequential organ failure assessment score on study day, solid organ malignancy, presence of severe sepsis or shock, Candida spp. infection, renal replacement treatment, and a nurse-to-patient ratio of 1:4 (compared with a nurse-to-patient ratio of 1:2) were independent predictors of mortality in infected patients.

Conclusions

A high prevalence of sepsis and an unacceptably high mortality rate were observed in Turkish ICUs. Although the prevalence of carbapenem resistance was high in Turkish ICUs, it was not associated with a higher risk for mortality.

Trial registration

ClinicalTrials.gov ID NCT03249246. Date: August 15, 2017. Retrospectively registered.
Appendix
Available only for authorised users
Literature
1.
Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitation. Am J Respir Crit Care Med. 2016;193:259–72.CrossRefPubMed
2.
Kumar G, Kumar N, Taneja A, Kaleekal T, Tarima S, McGinley E, et al. Milwaukee Initiative in Critical Care Outcomes Research Group of Investigators. Nationwide trends of severe sepsis in the 21st century (2000–2007). Chest. 2011;140:1223–31.CrossRefPubMed
3.
SepNet Critical Care Trials Group. Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study. Intensive Care Med. 2016;42:1980–9.CrossRef
4.
Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med. 2007;35:1244–50.CrossRefPubMed
5.
Whittaker SA, Fuchs BD, Gaieski DF, Christie JD, Goyal M, Meyer NJ, et al. Epidemiology and outcomes in patients with severe sepsis admitted to the hospital wards. J Cric Care. 2015;30:78–84.CrossRef
6.
Degoricija V, Sharma M, Legac A, Gradiser M, Sefer S, Vucicevic Z. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy. Croat Med J. 2006;47:385–97.PubMedPubMedCentral
7.
Walkey AJ, Lagu T, Lişndenauer PK. Trends in infection and sepsis sources in the United States. A population-based study. Ann Am Thorac Soc. 2015;12:216–20.CrossRefPubMedPubMedCentral
8.
Zimmerman JE, Kramer AA, Knaus WA. Changes in hospital mortality for United States intensive care unit admissions from 1988 to 2012. Crit Care. 2013;17:R81.CrossRefPubMedPubMedCentral
9.
Miller RR, Dong L, Nelson NC, Brown SM, Kuttler KG, Probst DR, et al. Multicenter implementation of a severe sepsis and septic shock treatment bundle. Am J Respir Crit Care Med. 2013;188:77–82.CrossRefPubMedPubMedCentral
10.
Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546–54.CrossRefPubMed
11.
Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA. 2014;311:1308–16.CrossRefPubMed
12.
Cheng B, Xi EG, Yao S, Wu X, Guo Q, Gu M, et al. Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China. Crit Care Med. 2007;35:2538–46.CrossRefPubMed
13.
Zhou J, Qian C, Zhao M, Yu X, Kang Y, Ma X, et al. Epidemiology and outcome of severe sepsis and septic shock in intensive care units in mainland China. PLoS One. 2014;9:e107181.CrossRefPubMedPubMedCentral
14.
Phua J, Koh Y, Du B, Tang YQ, Divatia JV, Tan CC, et al. Management of severe sepsis in patients admitted to Asian intensive care units: prospective cohort study. BMJ. 2011;342:d3245.CrossRefPubMedPubMedCentral
15.
16.
Daikos GL, Petrikkos P, Psichogiou M, Kosmidis C, Vryonis E, Skoutelis A, et al. Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob Agents Chemother. 2009;53:1868–73.CrossRefPubMedPubMedCentral
17.
Playford EG, Craig JC, Iredell JR. Carbapenem-resistant Acinetobacter baumanii in intensive care unit patients:risk factors for acquisition, infection and their consequences. J Hosp Infect. 2007;65:204–11.CrossRefPubMed
18.
Falagas ME, Rafailidis PI, Kofteridis D, Virtzili S, Chelvatzoglou FC, Papaioannou V, et al. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. J Antimicrob Chemother. 2007;60:1124–30.CrossRefPubMed
19.
Gaviria D, Bixler D, Thomas CA, Ibrahim SM, Kallen A, Limbago B, et al. Carbapenem-resistant Klebsiella pneumoniae associated with a long-term–care facility—West Virginia, 2009– 2011. MMWR Morb Mortal Wkly Rep. 2011;60:1418–20.
20.
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644–55.CrossRefPubMed
21.
Calandra T, Cohen J, International Sepsis Forum Definition of Infection in the ICU Consensus Conference. International sepsis forum definition of infection in the intensive care unit. Crit Care Med. 2005;33:1538–48.CrossRefPubMed
22.
Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, et al. Assessment of clinical criteria for sepsis: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:762–74.CrossRefPubMedPubMedCentral
23.
24.
Esen S, Leblebicioğlu H. Prevalence of nosocomial infections at intensive care units in Turkey: a multicentre 1-day point prevalence study. Scand J Infect Dis. 2004;36:144–8.CrossRefPubMed
25.
Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302:2323–9.CrossRefPubMed
26.
OECD. OECD Reviews of Health Care Quality: Turkey 2014: Raising standards. Paris: OECD Publishing; 2014.
27.
Bal MD. Nursing manpower planning approaches in hospital. J Health Nurs Manag. 2014;3:148–54.
28.
McGhan M, Kucharski G, Coyer F. Nurse staffing levels and the incidence of mortality and morbidity in the adult intensive care unit: a literature review. Aust Crit Care. 2012;25:64–77.CrossRef
29.
Numata Y, Schulzer M, van der Wal R, Globerman J, Semeniuk P, Balka E, et al. Nurse staffing levels and hospital mortality in critical care settings :literatüre review and meta-analysis. J Adv Nurs. 2006;55:435–48.CrossRefPubMed
30.
Neuraz A, Guérin C, Payet C, Polazzi S, Aubrun F, Dailler F, et al. Patient mortality is associated with staff resources and workload in the ICU: a multicenter observational study. Crit Care Med. 2015;43:1587–94.CrossRefPubMed
31.
Cho SH, Hwang JH, Kim J. Nurse staffing and patient mortality in intensive care units. Nurs Res. 2008;57:322–30.CrossRefPubMed
32.
Kübler A, Adamik B, Ciszewicz-Adamiczka B, Ostrowska E. Severe sepsis in intensive care units in Poland--a point prevalence study in 2012 and 2013. Anaesthesiol Intensive Ther. 2015;47:315–9.CrossRefPubMed
33.
Machado FR, Brazil CAB, Bozza F, Angus DC, Ferreira EM, Carrara F, et al. Epidemiology of sepsis in Brazilian ICUs: a nationwide stratified sample. Intensive Care Med. 2015;3:A642.CrossRef
34.
35.
Angus DC, Sirio CA, Clermont G, Bion J. International comparisons of critical care outcome and resource consumption. Crit Care Clin. 1997;13:389–407.CrossRefPubMed
36.
Levy MM, Rhodes A, Phillips GS, Townsend SR, Schorr CA, Beale R, et al. Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. Crit Care Med. 2015;43:3–12.CrossRefPubMed
37.
Rhodes A, Phillips G, Beale R, Cecconi M, Chiche JD, De Backer D, et al. The Surviving Sepsis Campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study). Intensive Care Med. 2015;41:1620–8.CrossRefPubMed
38.
Tanrıöver MD, Guven S, Sen D, Unal S, Uzun O. Epidemiology and outcome of sepsis in a tertiary-care hospital in a developing country. Epidemiol Infect. 2006;134:315–22.CrossRefPubMed
39.
Tufan ZK, Eser FC, Vudali E, Batirel A, Kayaaslan B, Bastug AT, et al. The knowledge of the physicians about sepsis bundles is suboptimal: a multicenter survey. J Clin Diagn Res. 2015;9:OC13–6.PubMedPubMedCentral
40.
Danai PA, Sinha S, Moss M, Haber MJ, Martin GS. Seasonal variation in the epidemiology of sepsis. Crit Care Med. 2007;35:410–5.CrossRefPubMed
41.
42.
Siddiqui S. Not “surviving sepsis” in the developing countries. J Coll Physicians Surg Pak. 2006;16:800–1.PubMed
43.
Frikha N, Mebazaa M, Mnif L, El Euch N, Abassi M, Ben Ammar MS. Septic shock in a Tunisian intensive care unit: mortality and predictive factors. 100 cases. Tunis Med. 2005;83:320–5.PubMed
44.
Maechler F, Pena Diaz LA, Schröder C, Geffers C, Behnke M, Gastmeier P. Infection. Prevalence of carbapenem-resistant organisms and other Gram-negative MDRO in German ICUs: first results from the national nosocomial infection surveillance system (KISS). Infection. 2015;43:163–8.CrossRefPubMed
45.
Sader HS, Farrell DJ, Flamm RK, Jones RN. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011). Diagn Microbiol Infect Dis. 2014;78:443–8.CrossRefPubMed
46.
Ben-David D, Kordevani R, Keller N, Tal I, Marzel A, Gal-Mor O, et al. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect. 2012;18:54–60.CrossRefPubMed
47.
48.
Paiva JA, Tabah A, Mikstacki A, de Carvalho FB, Koulenti D, Ruckly S, et al. Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study. Crit Care. 2016;20:53.CrossRefPubMedPubMedCentral
49.
Bassetti M, Righi E, Ansaldi F, Merelli M, Trucchi C, et al. A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. Intensive Care Med. 2014;40(6):839–45.CrossRefPubMed
Metadata
Title
Epidemiology of sepsis in intensive care units in Turkey: a multicenter, point-prevalence study
Authors
Nur Baykara
Halis Akalın
Mustafa Kemal Arslantaş
Volkan Hancı
Çiğdem Çağlayan
Ferda Kahveci
Kubilay Demirağ
Canan Baydemir
Necmettin Ünal
Sepsis Study Group
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2018
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-018-2013-1

Other articles of this Issue 1/2018

Critical Care 1/2018 Go to the issue

Research

Cerebral metabolic effects of strict versus conventional glycaemic targets following severe traumatic brain injury

Research

Feasibility of biventricular 3D transthoracic echocardiography in the critically ill and comparison with conventional parameters

Research

Resuscitative endovascular balloon occlusion of the aorta performed by emergency physicians for traumatic hemorrhagic shock: a case series from Japanese emergency rooms

Letter

Identification of developing multiple organ failure in sepsis patients with low or moderate SOFA scores

Letter

“Think. Check. Submit.” to avoid predatory publishing

Letter

Microcirculation in cardiogenic shock supported with extracorporeal membrane oxygenation: the need for a homogeneous population and strict evolution assessment